Suchergebnisse - "Janus Kinases"

PubPharm (18.778)

51

Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis

enthalten in: RMD open | 2024

von Song, Y. | Lee, J. | Jo, J. | +1

52

Janus kinase inhibitors and the changing landscape of vitiligo management : a scoping review

enthalten in: International journal of dermatology | 2024

von Utama, A. | Wijesinghe, R. | Thng, S.

53

Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib : A multicenter retrospective study

enthalten in: Journal of the American Academy of Dermatology | 2024

von Avallone, G. | Mastorino, L. | Tavoletti, G. | +33

54

LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling

enthalten in: Cancer gene therapy | 2024

von Yu, S. | Gao, X. | Liu, S. | +5

55

A JAK2 mutant to WT prothrombotic cross talk

enthalten in: Blood | 2024

von Benajiba, L.

CommentOn: Blood. 2024 Apr 11;143(15):1539-1550. - PMID 38142422

56

Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients : a patient-centered survey study

enthalten in: International journal of women's dermatology | 2024

von Nohria, A. | Zhang, Y. | Desai, D. | +5

57

Choosing immunomodulating therapies for the treatment of COVID-19 : recommendations based on placebo-controlled trial evidence

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Sweeney, D. | Lobo, S. | Póvoa, P. | +1

58

TYK2 : an emerging therapeutic target in rheumatic disease

enthalten in: Nature reviews. Rheumatology | 2024

von Morand, E. | Merola, J. | Tanaka, Y. | +2

59

Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3

enthalten in: Journal of clinical immunology | 2024

von Tsilifis, C. | Spegarova, J. | Good, R. | +7

60

Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Jiang, H. | Wang, Y. | Wen, D. | +9